Juxian Wang

2.4k total citations · 1 hit paper
97 papers, 2.0k citations indexed

About

Juxian Wang is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Juxian Wang has authored 97 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Organic Chemistry, 27 papers in Infectious Diseases and 25 papers in Molecular Biology. Recurrent topics in Juxian Wang's work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (18 papers) and Synthesis and biological activity (17 papers). Juxian Wang is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (18 papers) and Synthesis and biological activity (17 papers). Juxian Wang collaborates with scholars based in China, United States and Canada. Juxian Wang's co-authors include Mengdi Ma, Zheyuan Zhang, Tianyi Dong, Daqing Shi, Guoning Zhang, Liangce Rong, Qiya Zhuang, Xiang‐Shan Wang, Hongwen Hu and Shan Cen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Juxian Wang

90 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Do ESG ratings promote corporate green innovation? A quasi-natural experiment based on SynTao Green Finance's ESG ratings

2023 460 citations Juxian Wang, Mengdi Ma et al. International Review of Financial Analysis profile →

Peers

Countries citing papers authored by Juxian Wang

Since Specialization

Citations

This map shows the geographic impact of Juxian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juxian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juxian Wang more than expected).

Fields of papers citing papers by Juxian Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juxian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juxian Wang. The network helps show where Juxian Wang may publish in the future.

Co-authorship network of co-authors of Juxian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Juxian Wang. A scholar is included among the top collaborators of Juxian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juxian Wang. Juxian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer’s disease 2025 ·Science Advances ·(unknown), Lin Wang, Yue Li, (unknown), Juxian Wang, (unknown), Jian Sima	0
2	Novel Oxazolidinone Derivatives Containing Quaternary Ammonium Fragments with Potent Antibacterial Potency 2025 ·ACS Medicinal Chemistry Letters ·(unknown), Minghua Wang, Ying Wang, (unknown), Xiukun Wang, Ying Han, Xuefu You, Xinxin Hu, Mei Zhu, Guoning Zhang, Liyan Yu, Yucheng Wang, Juxian Wang	0
3	Rational design, synthesis, and evaluating primary biological activities of novel HIV-1 protease inhibitors containing heteraryl acetamides as the P2 ligands 2025 ·Bioorganic & Medicinal Chemistry ·(unknown), Yu Gao, Qingqing Yang, Ling Ma, Biao Dong, Juxian Wang, Guoning Zhang, Minghua Wang, Shan Cen, (unknown), (unknown), Yucheng Wang	0
4	Rational design, synthesis and biological evaluation of novel HIV-1 protease inhibitors containing 2-phenylacetamide derivatives as P2 ligands with potent activity against DRV-Resistant HIV-1 variants 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Yu Gao, (unknown), Zhiwei Hu, Qi Shan, Juxian Wang, Yucheng Wang, Jie Mou	3
5	Do ESG ratings promote corporate green innovation? A quasi-natural experiment based on SynTao Green Finance's ESG ratings breakdown → 2023 ·International Review of Financial Analysis ·Juxian Wang, Mengdi Ma, Tianyi Dong, Zheyuan Zhang	460
6	Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C 2022 ·European Journal of Medicinal Chemistry ·(unknown), Huiyu Zhou, Ling Ma, Biao Dong, Jiwei Ding, Jinming Zhou, Juxian Wang, Guoning Zhang, Minghua Wang, (unknown), Shan Cen, (unknown)	6
7	Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Ling Ma, Biao Dong, Juxian Wang, Guoning Zhang, Minghua Wang, Jinming Zhou, Shan Cen, (unknown)	6
8	Rational Design and Systemic Appraisal of an EGFR-Targeting Antibody–Drug Conjugate LR-DM1 for Pancreatic Cancer 2022 ·Journal of Medicinal Chemistry ·(unknown), Lei Zhou, (unknown), (unknown), Jianhua Gong, Na Zhang, Guoning Zhang, Minghua Wang, Juxian Wang, (unknown), Yucheng Wang	6
9	Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors 2021 ·European Journal of Medicinal Chemistry ·Guoning Zhang, Jian‐Yuan Zhao, Quanjie Li, Minghua Wang, (unknown), Juxian Wang, Shan Cen, (unknown)	20
10	Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants 2021 ·European Journal of Medicinal Chemistry ·(unknown), Huiyu Zhou, Ling Ma, Biao Dong, Jinming Zhou, Guoning Zhang, Minghua Wang, Juxian Wang, Shan Cen, Yucheng Wang	19
11	Design, synthesis and anti-influenza A virus activity of novel 2,4-disubstituted quinazoline derivatives 2020 ·Bioorganic & Medicinal Chemistry Letters ·Minghua Wang, Guoning Zhang, Yujia Wang, Juxian Wang, (unknown), Shan Cen, Yucheng Wang	32
12	A novel biphenyl compound IMB-S7 ameliorates hepatic fibrosis in BDL rats by suppressing Sp1-mediated integrin αv expression 2020 ·Acta Pharmacologica Sinica ·Na Zhang, Shuangshuang Zhao, (unknown), Yucheng Wang, Rong‐Guang Shao, Juxian Wang, Hongwei He	11
13	Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants 2019 ·European Journal of Medicinal Chemistry ·(unknown), Ling Ma, Huiyu Zhou, Biao Dong, Yujia Wang, Zhen Wang, Jinming Zhou, Guoning Zhang, Juxian Wang, Chen Liang, Shan Cen, Yucheng Wang	24
14	Design, Synthesis, and Biological Evaluation of Phenol Bioisosteric Analogues of 3-Hydroxymorphinan 2019 ·Scientific Reports ·Ziqiang Li, Xiu‐Qi Bao, (unknown), Guoning Zhang, Juxian Wang, Mei Zhu, Yue Wang, (unknown), (unknown), Dan Zhang, Yucheng Wang	5
15	Synthesis and Biological Evaluation of Substituted Indole and Its Analogs as Influenza A Virus Inhibitors 2018 ·Chemistry & Biodiversity ·(unknown), (unknown), Yujia Wang, (unknown), Juxian Wang, Ziqiang Li, Donghui Li, Shan Cen, (unknown), (unknown)	7
16	Design and synthesis of potent HIV-1 protease inhibitors with ( S )-tetrahydrofuran-tertiary amine-acetamide as P2−ligand: Structure−activity studies and biological evaluation 2017 ·European Journal of Medicinal Chemistry ·(unknown), Zhiheng Yang, (unknown), Biao Dong, Lei Zhou, Guoning Zhang, Juxian Wang, Yucheng Wang	19
17	Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains 2016 ·Bioorganic & Medicinal Chemistry ·Ziqiang Li, (unknown), Qi Deng, Guoning Zhang, Lei Zhou, Yishuang Liu, Juxian Wang, Yucheng Wang	29
18	Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands 2015 ·Bioorganic & Medicinal Chemistry Letters ·Zhiheng Yang, (unknown), Lei Zhou, Juxian Wang, Hongtao Liu, Yucheng Wang	16
19	tert-ButylN-[2-(N-isobutyl-4-methoxybenzenesulfonamido)ethyl]carbamate 2014 ·Acta Crystallographica Section E Structure Reports Online ·(unknown), Juxian Wang	1
20	Effects of curcumin on contents of SOD and MDA in brain of neonatal rats with hypoxic-ischemic encephalopathy 2013 ·Zhongguo yaolixue tongbao ·Juxian Wang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact